Stock Market Alert's performance stock list includes: Dragon
Capital Group Corp (PINKSHEETS: DRGV), Human Genome Sciences Inc
(NASDAQ: HGSI), Matrixx Initiatives, Inc. (NASDAQ: MTXX) and Gilead
Sciences, Inc. (NASDAQ: GILD).
Breaking News: Market Advisors, Inc. issues "Initiating
Coverage" Report on Dragon Capital Group (PINKSHEETS: DRGV) with a
speculative buy and a price objective of $0.047 per Share. The
company, a leading holding company of emerging high-tech companies
in China, issued a press release early this morning announcing that
a new research report has been issued regarding Dragon Capital
Group Corporation by Market Advisors, Inc. "Fundamental Analysis
for Today's Investments" with a "Speculative Buy" and a $0.047
intermediate price objective.
To view the report, please visit www.dragoncapital.us a leading
holding company of emerging high-tech companies in China.
Last week, the company reported announced its financial results
for the second quarter ended June 30, 2009. Financial highlights
included:
Revenue for the second quarter ended June 30, 2009 was $15.0
million, a 27% increase over the $11.8 million recorded in the
second quarter of 2008. Cost of goods sold for the second quarter
of 2009 were $14.1 million compared to $11.2 million in the second
quarter of 2008. Net income from continuing operations for the
second quarter of 2009 was $124,500, increasing from the $31,000
recorded in the first quarter of 2009. Net income in the second
quarter of 2008 was approximately $215,000. This decrease in net
income was largely attributable to an increase in selling expenses
as a result of the challenging economic environment.
Revenue for the first six months of 2009 reached $26.9 million,
increasing by 20% from the $22.3 million recorded in the first six
months of 2008. For the first six months of 2009, net income from
continuing operations was $155,400 down from $450,800 in the first
six months of 2008 and mainly attributed to higher selling expenses
in 2009.
At June 30, 2009, total assets were $14.6 million compared to
$15.9 million at December 31, 2008. At June 30, 2009, shareholder
equity was $7.1 million and total current assets were $14.3 million
with working capital of approximately $7.8 million.
The stock closed yesterday at under a Penny a share.
For an in-depth profile of Dragon Capital Group, visit
http://www.wallstreetenews.com/view-company-profiles.php?profile=DRGV_072109.
To receive FREE Mobile Stock Alerts formatted especially for
your cell phone, text the word "press" in the subject line to
68494.
*** This free service can be discontinued at any time by
replying to any one of the alerts with the word "stop"
Human Genome Sciences Inc (NASDAQ: HGSI) up 11.7% on 23.5
million shares traded. Human Genome Sciences is a commercially
focused biopharmaceutical company. In the first half of 2009, HGS
achieved its first product revenues of $162.7 million when we
delivered raxibacumab (ABthrax(TM)) to the U.S. Strategic National
Stockpile for the treatment of inhalation anthrax. HGS has two
other products in late-stage clinical development: ZALBIN(TM)
(formerly Albuferon(®)) for chronic hepatitis C and BENLYSTA(TM)
(formerly LymphoStat-B(®)) for systemic lupus erythematosus.
Matrixx Initiatives, Inc. (NASDAQ: MTXX) up 22.3% on 8.5 million
shares traded. Matrixx Initiatives, Inc. is engaged in the
development and marketing of over-the-counter healthcare products
that utilize innovative drug delivery systems.
Gilead Sciences, Inc. (NASDAQ: GILD) up 0.5% on 5.7 million
shares traded. Gilead Sciences is a biopharmaceutical company that
discovers, develops and commercializes innovative therapeutics in
areas of unmet medical need.
This advertisement is provided by Wall Street Enews, a division
of Stock Market Alerts LLC, an electronic broadcaster and publisher
of this release, and hereafter referred to as "the company." The
company also maintains a contractual, working relationship with
Wall Street Capital Funding LLC. and its Wall Street News Alert
brand. For current services performed for Dragon Capital Group Corp
(PINKSHEETS: DRGV), China Direct Industries, Inc. ("China Direct
Industries"), Sunwin International Neutraceuticals, Inc., China
America Holdings and China Armco Metals, Inc., the company has been
compensated a total of Fifty Thousand Dollars by China Direct
Investments Inc., a Florida corporation, and a wholly owned
subsidiary of China Direct. The company does not hold any shares of
the stock. Because the company received compensation for its
services, there is an inherent conflict of interest in the company
statements and opinions and such statements and opinions cannot be
considered independent.
The information contained in this press release is for
informational purposes only, and not to be construed as an offer to
sell or solicitation of an offer to buy any security. The company
makes no representation or warranty relating to the validity of the
facts presented nor does the company represent or warrant that all
material facts necessary to make an investment decision are
presented above. Stock Market Alerts LLC is an advertising company
and therefore, this release should be viewed for informational
purposes only.
The company relies exclusively on information gathered on the
public company, such as public filings, press releases and its web
sites. Investors should use the advertising information contained
in this release as a starting point for conducting additional
research on the public company in order to allow the investor to
form his or her own opinion regarding the public company. Factual
statements contained in this publication are made as of the date
stated and they are subject to change without notice. The company
is not a registered investment adviser, broker or a dealer.
Investing in the public company that this release is providing
service for should be reviewed as speculative and a high-risk and
may result in the loss of some or all of any investment.
This release may contain statements that constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended. The words "may," "would," "will,"
"expect," "estimate," "anticipate," "believe," "intend," and
similar expressions and variations thereof are intended to identify
forward-looking statements.
NASDAQ:MTXX NASDAQ:GILD PINKSHEETS:DRGV NASDAQ:HGSI
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024